Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
Sponsor: University of Alabama at Birmingham
Summary
The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. We believe that GWI involves inflammation in the body and brain that causes fatigue, pain, cognitive disruption, and other symptoms. Botanicals that reduce inflammation may help treat GWI.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-02-01
Completion Date
2027-02-01
Last Updated
2025-12-05
Healthy Volunteers
No
Conditions
Interventions
Placebo
The placebo being used in this study is microcrystalline cellulose. This will be taken orally, up to twice per day.
Pycnogenol, 100mg
Pycnogenol being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug. This will be taken orally, up to twice per day.
Pycnogenol, 200mg
Pycnogenol being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug. This will be taken orally, up to twice per day.
Pycnogenol, 400mg
Pycnogenol being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug. This will be taken orally, up to twice per day.
Pycnogenol, 600mg
Pycnogenol being used in this study is a commercially available dietary supplement and is classified as food by the FDA instead of a drug. This will be taken orally, up to twice per day.
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States